Pharmaceutical giant Pfizer has unveiled encouraging mid-stage trial results for berobenatide, an experimental anti-obesity and diabetes drug designed to be taken just once a month. If approved, it ...

*A gene therapy that may eliminate, or significantly reduce, the need for daily insulin injections is preparing to enter human trials for the first time, offering fresh hope to hundreds of thousands ...

A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to ...

For millions of people living with high cholesterol, the routine is familiar and exhausting: a pill every morning, an injection every few weeks, blood tests every few months, all to keep LDL, the ...